Month: March 2020

PHOENIX, March 27, 2020 (GLOBE NEWSWIRE) — Mobivity Holdings Corp. (MFON), creators of the award-winning customer personalization platform, Recurrency, today announced that the Company will release results for the fourth quarter and year ended December 31, 2019 on Monday, March 30, 2020 after the market close and has scheduled a conference call for the same day at 4:30 P.M. Eastern Time (ET).Conference Call Information:Date: Monday, March 30, 2020Time: 4:30 P.M. Eastern Time (ET)Dial in Number for U.S. Callers: 1 (877) 705-6003Dial in Number for International Callers: 1 (201) 493-6725Please Reference Conference ID: 13700252The call will also be accompanied live by webcast over the Internet and accessible here.Participating on the call will be Mobivity Holding Corp.’s Chairman and Chief Executive Officer, Dennis Becker, and Chief...

EMA CHMP positive opinion in non-radiographic axial spondyloarthritis (nr-axSpA) paves way for fourth indication in Europe, and is based on Phase III PREVENT data1 If approved, Cosentyx would become the first fully-human IL-17A inhibitor indicated for patients in Europe with nr-axSpA There are approximately 1.7 million patients with nr-axSpA in the top five EU countries and US, which forms part of the axial spondyloarthritis (axSpA) disease spectrum2 Cosentyx is backed by five years of clinical data supporting long-term safety and efficacy across ankylosing spondylitis (AS), psoriatic arthritis (PsA) and moderate-to-severe plaque psoriasis (PsO)3-6Basel, March 27, 2020 — Novartis, a leader in rheumatology and immuno-dermatology,  today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

Zolgensma® (onasemnogene abeparvovec), a one-time administered gene therapy, has been recommended for European Commission (EC) conditional approval for patients with spinal muscular atrophy (SMA) and a clinical diagnosis of Type 1 or SMA patients with up to three copies of the SMN2 gene Zolgensma has demonstrated significant and clinically meaningful therapeutic benefit in presymptomatic and symptomatic SMA, including prolonged event-free survival and achievement of motor milestones unseen in natural history of the disease and to date, sustained for 5 years post-dosing In Europe, SMA is a significant burden to the healthcare system with cumulative estimated healthcare costs per child ranging between €2.5 to €4 million within the first 10 years alone1 To support the urgent need to treat SMA as early as possible, AveXis is offering an innovative...

YERINGTON, Nev., March 27, 2020 (GLOBE NEWSWIRE) — Nevada Copper Corp. (TSX: NCU) (“Nevada Copper” or the “Company’’) is pleased to announce the execution of definitive agreements in respect of the Company’s proposed substantial balance sheet strengthening package announced on March 18, 2020.The financing package provides improved flexibility for the Company’s balance sheet whilst ramping-up operations and in light of the substantial macro-economic uncertainty and depressed copper prices.Nevada Copper has in place COVID-19 response plans and currently its operations are continuing with limited disruption. However, there are no guarantees that in the future further work restrictions will not be required, or government mandated, as events continue to unfold relating to COVID-19.Matt Gili, Chief Executive Officer, commented: “The successful...

NEW YORK, March 27, 2020 (GLOBE NEWSWIRE) — Prospect Capital Corporation (the “Company”) today announced the results of its previously announced cash tender offer (the “Tender Offer”) to purchase any and all of the outstanding notes listed below. The Tender Offer was made pursuant to an Offer to Purchase dated March 20, 2020 (the “Offer to Purchase”), which set forth the terms and conditions of the Tender Offer.As of the previously announced expiration time of 5:00 p.m., New York City time, on March 26, 2020 (the “Expiration Time”), according to information provided by D.F. King & Co., Inc., the information and tender agent for the Tender Offer, a total of $654,600 aggregate principal amount of Notes (defined below) had been validly tendered and not validly withdrawn in the Tender Offer. This amount includes $0 tendered pursuant...

NEW YORK, March 27, 2020 (GLOBE NEWSWIRE) — via NetworkNewsAudio – Sigma Labs Inc. (NASDAQ: SGLB)  announces the availability of a broadcast titled, “Transformative Software Unleashes 3D Printing Industry.”To hear the AudioPressRelease from NetworkNewsAudio, visit: http://nnw.fm/dgG0DTo read the full editorial, visit: http://nnw.fm/Ngl0VThe full promise of 3D metal printing is imminent as long-sought quality-control systems provide newfound ability to scale additive metal manufacturing.From its inception by scientists at Los Alamos, Sigma Labs Inc. (NASDAQ: SGLB) has led the world in developing software that addresses serious quality-assurance issues in 3D metal printing. Now the company has moved from beta development and third-party validation to commercialization in an untapped $2 billion market as the only known provider of...

NEW YORK, March 27, 2020 (GLOBE NEWSWIRE) — With the COVID-19 pandemic escalating in the U.S., SCWorx Corp. (Nasdaq: WORX) announced today an agreement between its subsidiary Direct Worx and an existing large hospital customer to supply one million surgical masks, which were fulfilled and shipped yesterday. The initial agreement was for $390,000, with additional potential agreements to help hospitals source urgently needed Personal Protective Equipment (PPE) are anticipated.“Hospitals are quickly running out of surgical masks and other PPE as the number of COVID-19-infected patients accelerates beyond hospitals’ ability to procure needed PPE to protect patients, doctors, nurses and other hospital personnel treating infected patients,” said Marc Schessel, CEO of SCWorx. “Our subsidiary, Direct Worx utilizes our extensive hospital...

Nominees Include James J. Martell and James L. WelchCompany Announces Agreement with Saddle Point Management, L.P.BANNOCKBURN, Ill., March 27, 2020 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) (“Stericycle” or the “Company”) today announced that its Board of Directors has agreed to nominate James J. Martell (“Jim”), former Chief Executive Officer of Express-1, the predecessor company to XPO Logistics, and James L. Welch, former Chief Executive Officer of YRC Worldwide, as director nominees to stand for election to the Board at the Company’s 2020 Annual Meeting of Stockholders.The director nominations follow ongoing discussions with Saddle Point Management, L.P. (“Saddle Point”), a current investor in the Company. In connection with the Board’s agreement to nominate Mr. Martell and Mr. Welch, Stericycle and Saddle Point have...